首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1542588

全球光化性角化症治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Actinic Keratosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球光化性角化症治療市場的需求預計將從 2023 年的 70.2 億美元達到 2032 年近 111.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.3%。

皮膚表面出現厚厚的鱗狀或硬皮斑塊，顯示癌前病變，稱為光化性角化症。光化性角化症是常見的問題。人們的心態和生活方式正在發生變化，消費者對護膚品進行投資。這在光化性角化症治療市場中發揮重要作用。光化性角化症的治療過程是最低限度的干擾。治療程序接受度的提高刺激了市場。癌症發生率的上升、慢性病盛行率的增加以及久坐的生活方式正在推動全球光化性角化病治療產業的發展。預計在預測期內將出現良好的成長。

市場動態

全球光化性角化症治療市場正在經歷成長。推動光化性角化症治療市場的決定因素有多種。最明顯的因素之一是光化性角化病患病率的增加。適當的醫療保險和關注的可用性，以及過度陽光照射和臭氧層消耗等環境因素，歸因於角化病治療市場。另一方面，治療的高成本和風險因素減緩了其市場成長。然而，它確實有改進和加強的潛力。

該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。

此外，這些工具還對全球光化性角化病治療市場中的每個應用/產品領域進行了包容性評估。

市場區隔

整個光化性角化症治療市場已細分為治療、藥物類別、最終用途前景。該報告根據地理細分對這些子集進行了分析。這項研究將使行銷人員了解情況，並有助於確定產品或服務的目標族群。

透過治療

專題
手術
光動力療法
按藥物類別
核苷代謝抑制劑
非類固醇抗發炎藥
免疫反應調節劑
光增強劑
其他
按最終用途
醫院
私人診所
居家護理
其他
區域分析

本節涵蓋區域細分，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲光化性角化病治療市場當前和未來的需求。此外，該報告重點關注所有主要地區對個別應用領域的需求。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。光化性角化症治療市場的主要參與者包括 Almirall SA、LEO Pharma A/S、Sun Pharmaceutical Industries Ltd.、諾華 AG、Galderma、Ortho Dermatologics (Bausch Health Companies Inc.) 和 Biofrontera AG。本節包括競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：光化性角化症治療公司的競爭格局

光化性角化症治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Almirall SA

公司概況
公司收入
產品
最新動態

LEO Pharma A/S

公司概況
公司收入
產品
最新動態

Sun Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Galderma

公司概況
公司收入
產品
最新動態

Ortho Dermatologics (Bausch Health Companies Inc.)

公司概況
公司收入
產品
最新動態

Biofrontera AG

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211663

The global demand for Actinic Keratosis Treatment Market is presumed to reach the market size of nearly USD 11.17 Billion by 2032 from USD 7.02 Billion in 2023 with a CAGR of 5.3% under the study period 2024 - 2032.

The presence of thick, scaly or crusty patches on the skin surface indicating premalignant condition is referred as actinic Keratosis. Actinic Keratosis is a commonly found problem. The mindset and lifestyle of people is shifting and consumers invest on skin care. This plays a major role in the actinic Keratosis treatment market. The actinic Keratosis treatment procedures are minimally obtrusive. Increase in acceptance of therapeutic procedures combust the market. Rising incidences of cancer, increasing prevalence off chronic diseases and sedentary lifestyle are driving the global actinic Keratosis treatment industry. It is predicted to have a favorable growth over the forecasted period.

Market Dynamics

The global actinic Keratosis treatment market is experiencing a growth. There are various determinants that propel the actinic Keratosis treatment market. One of the most obvious factors is the increasing prevalence of actinic Keratosis. The availability of suitable medical coverage and attention, along with environmental factors such as excessive sun exposure and depletion in the ozone layer, attribute to the Keratosis treatment market. On the other hand, the high cost and the risk factors involved with the treatment have slowed down its market growth. However, it does have the potential to improve and accentuate.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of actinic keratosis treatment.

Market Segmentation

The entire actinic keratosis treatment market has been sub-categorized into therapy, drug class, end use outlook. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Therapy

Topical
Surgery
Photodynamic Therapy
By Drug Class
Nucleoside Metabolic Inhibitors
NSAIDs
Immune Response Modifiers
Photoenhancers
Others
By End Use
Hospitals
Private Clinics
Homecare
Others
Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for actinic keratosis treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Actinic Keratosis Treatment market include Almirall S.A., LEO Pharma A/S, Sun Pharmaceutical Industries Ltd., Novartis AG, Galderma, Ortho Dermatologics (Bausch Health Companies Inc.), Biofrontera AG. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ACTINIC KERATOSIS TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapy
- 3.7.2 Market Attractiveness Analysis By Drug Class
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY THERAPY

5.1. Overview By Therapy
5.2. Historical and Forecast Data
5.3. Analysis By Therapy
5.4. Topical Historic and Forecast Sales By Regions
5.5. Surgery Historic and Forecast Sales By Regions
5.6. Photodynamic Therapy Historic and Forecast Sales By Regions

6. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY DRUG CLASS

6.1. Overview By Drug Class
6.2. Historical and Forecast Data
6.3. Analysis By Drug Class
6.4. Nucleoside Metabolic Inhibitors Historic and Forecast Sales By Regions
6.5. NSAIDs Historic and Forecast Sales By Regions
6.6. Immune Response Modifiers Historic and Forecast Sales By Regions
6.7. Photoenhancers Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Private Clinics Historic and Forecast Sales By Regions
7.6. Homecare Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ACTINIC KERATOSIS TREATMENT COMPANIES

9.1. Actinic Keratosis Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ACTINIC KERATOSIS TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Almirall S.A.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. LEO Pharma A/S
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sun Pharmaceutical Industries Ltd.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Novartis AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Galderma
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Ortho Dermatologics (Bausch Health Companies Inc.)
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Biofrontera AG
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments